IDYA

NASD IDEAYA Biosciences, Inc.
Oct 21, 2026 · 6:37 PM ET LAST TRADE Market Closed

$35.47 ↑ +0.00 (+0.00%) Trading Up from the previous close of $35.47, $0.64 below the day’s high of $36.11

YTD change
+2.60%
vs 20-day SMA
-1.98%
vs 200-day SMA
+3.96%

Price ranges

Previous day
$33.74 $35.63
open $33.93 close $35.36
+$1.43 (+4.21%)
Today
$35.33 $36.11
open $35.43 now $35.47
+$0.04 (+0.11%)
Past week
$32.72 $35.63
from $34.26 now $35.47
+$1.21 (+3.53%)
Past month
$32.72 $39.88
from $39.71 now $35.47
-$4.24 (-10.68%)
This year
$26.81 $42.68
from $34.57 now $35.47
+$0.90 (+2.60%)

Price & Performance

+3.53 (+11.09%) / 6M

$26.41$32.16$37.92$43.67Apr 21Jul 22Oct 20

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 25.7% away from all-time highs of $47.74
  • IDYA is up 3% since the beginning of the year
  • IDYA is up 21% over the past 12 months
  • IDYA is down 11% over the past 1 month
  • 9% of all IDYA investors are betting against IDYA

IDYA reads very good: price sits above one of the two key moving averages, the 12-month move is +21.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-1.22
Earnings momentum -3.9% Quarterly EPS growth
Quarterly change -3.9%

Valuation

P/E ratio N/A
Enterprise value $2.5B
Beta 0.41

Balance sheet & scale

IncomeN/A
Revenue$234.1M
Cash$829.0M
Debt$29.3K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $3.5B

IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. The firm focuses on the targeted therapeutics for patients selected using molecular diagnostics. Its product candidate, IDE196, is a protein kinase C inhibitor for genetically defined cancers having GNAQ and GNA11 gene mutations. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $438.94 +3.29%
MRNA Moderna, Inc. $242.08 +6.69%
RVMD Revolution Medicines, Inc. $196.55 +7.91%
ROIV Roivant Sciences Ltd. $34.92 +0.63%
BNTX BioNTech SE Sponsored ADR $91.17 +2.20%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.